Annelieke Zeilemaker

1.8k total citations
13 papers, 705 citations indexed

About

Annelieke Zeilemaker is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Annelieke Zeilemaker has authored 13 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Annelieke Zeilemaker's work include Acute Myeloid Leukemia Research (11 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Genomics and Diagnostics (3 papers). Annelieke Zeilemaker is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Genomics and Diagnostics (3 papers). Annelieke Zeilemaker collaborates with scholars based in Netherlands, Germany and Oman. Annelieke Zeilemaker's co-authors include Peter J.M. Valk, Bob Löwenberg, Saman Abbas, François G. Kavelaars, Jasper Koenders, Anita W. Rijneveld, Anita M. Schelen, Sanne Lugthart, Mathijs A. Sanders and Claudia Erpelinck-Verschueren and has published in prestigious journals such as Blood, Experimental Cell Research and Molecular Endocrinology.

In The Last Decade

Annelieke Zeilemaker

12 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annelieke Zeilemaker Netherlands	8	478	438	216	180	81	13	705
Serena Lavorgna Italy	16	484 1.0×	504 1.2×	118 0.5×	171 0.9×	144 1.8×	30	771
Giuseppina Fugazza Italy	13	330 0.7×	230 0.5×	226 1.0×	52 0.3×	77 1.0×	36	599
Jinlan Pan China	13	369 0.8×	234 0.5×	177 0.8×	63 0.3×	115 1.4×	104	603
Emilia Giugliano Italy	11	269 0.6×	201 0.5×	158 0.7×	49 0.3×	53 0.7×	37	438
F-X Mahon France	15	496 1.0×	180 0.4×	370 1.7×	40 0.2×	42 0.5×	26	682
Sandra Heesch Germany	15	368 0.8×	382 0.9×	81 0.4×	98 0.5×	376 4.6×	21	777
Monique Passier Netherlands	10	144 0.3×	260 0.6×	84 0.4×	75 0.4×	187 2.3×	11	490
Ema Anastasiadou United States	6	351 0.7×	254 0.6×	121 0.6×	30 0.2×	100 1.2×	7	500
Markéta Žaliová Czechia	18	504 1.1×	348 0.8×	93 0.4×	177 1.0×	574 7.1×	59	974
Adriana Puma Italy	12	163 0.3×	141 0.3×	140 0.6×	60 0.3×	29 0.4×	22	452

Countries citing papers authored by Annelieke Zeilemaker

Since Specialization

Citations

This map shows the geographic impact of Annelieke Zeilemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annelieke Zeilemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annelieke Zeilemaker more than expected).

Fields of papers citing papers by Annelieke Zeilemaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annelieke Zeilemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annelieke Zeilemaker. The network helps show where Annelieke Zeilemaker may publish in the future.

Co-authorship network of co-authors of Annelieke Zeilemaker

This figure shows the co-authorship network connecting the top 25 collaborators of Annelieke Zeilemaker. A scholar is included among the top collaborators of Annelieke Zeilemaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annelieke Zeilemaker. Annelieke Zeilemaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Zeilemaker, Annelieke, Melissa Rijken, François G. Kavelaars, et al.. (2024). Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis. Blood Advances. 9(6). 1344–1355. 2 indexed citations

Hinai, Adil S. A. Al, Tim Grob, Melissa Rijken, et al.. (2021). PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse. Leukemia. 35(9). 2693–2697. 6 indexed citations

Jutzi, Jonas S., S Kaiser, Doris Steinemann, et al.. (2019). Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood. 133(16). 1766–1777. 20 indexed citations

Sanders, Mathijs A., Edward Chew, Christoffer Flensburg, et al.. (2018). MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML. Blood. 132(14). 1526–1534. 76 indexed citations

Jongen‐Lavrencic, Mojca, Tim Grob, François G. Kavelaars, et al.. (2017). Prospective Molecular MRD Detection By NGS: A Powerful Independent Predictor for Relapse and Survival in Adults with Newly Diagnosed AML. Blood. 130(Suppl_1). LBA–5. 3 indexed citations

Sanders, Mathijs A., Anikó Szabó, Remco M. Hoogenboezem, et al.. (2016). Extensive RAG-Mediated Rearrangements and Mutations in BCR-ABL1 and BCR-ABL1-like Adult Acute Lymphoblastic Leukemia. Blood. 128(22). 4067–4067.

Sanders, Mathijs A., Annelieke Zeilemaker, Adil Al Hinai, et al.. (2016). DNMT3A Mutations Enhance CpG Mutagenesis through Deregulation of the Active DNA Demethylation Pathway. Blood. 128(22). 1076–1076. 1 indexed citations

Gröschel, Stefan, Mathijs A. Sanders, Remco M. Hoogenboezem, et al.. (2014). Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways. Blood. 125(1). 133–139. 55 indexed citations

Abbas, Sakina, Matthew A. Sanders, Annelieke Zeilemaker, et al.. (2014). Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations. Haematologica. 99(5). 848–857. 25 indexed citations

10.

Pratcorona, Marta, Claudia Erpelinck-Verschueren, Veronika Ročková, et al.. (2012). Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood. 119(24). 5824–5831. 185 indexed citations

11.

Abbas, Saman, Sanne Lugthart, François G. Kavelaars, et al.. (2010). Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value. Blood. 116(12). 2122–2126. 284 indexed citations

12.

Fanelli, Francesca, Miriam Verhoef‐Post, M. A. Timmerman, et al.. (2004). Insight into Mutation-Induced Activation of the Luteinizing Hormone Receptor: Molecular Simulations Predict the Functional Behavior of Engineered Mutants at M398. Molecular Endocrinology. 18(6). 1499–1508. 32 indexed citations

13.

Zeilemaker, Annelieke, et al.. (2004). Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts. Experimental Cell Research. 297(2). 434–443. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact